The immunogenicity and safety of different COVID-19 booster vaccination following CoronaVac or ChAdOx1 nCoV-19 primary series

Nasikarn Angkasekwinai, Suvimol Niyomnaitham, Jaturong Sewatanon, Supaporn Phumiamorn, Kasama Sukapirom, Sansnee Senawong, Surakameth Mahasirimongkol, Zheng Quan Toh, Pinklow Umrod, Thitiporn Somporn, Supaporn Chumpol, Kanokphon Ritthitham, Kulkanya Chokephaibulkit
doi: https://doi.org/10.1101/2021.11.29.21266947

Article usage

Article usage: November 2021 to December 2024

AbstractFullPdf
Nov 2021343099
Dec 202130131261039
Jan 2022101276648
Feb 202281264382
Mar 202257551461
Apr 20223865202
May 20223116145
Jun 20222907119
Jul 2022185190
Aug 20221851597
Sep 20221891388
Oct 2022163269
Nov 2022130346
Dec 2022100032
Jan 2023811033
Feb 202393747
Mar 202391422
Apr 202377341
May 202364422
Jun 202355515
Jul 202353223
Aug 2023521123
Sep 202352685
Oct 202354325
Nov 2023571613
Dec 202332010
Jan 202430331
Feb 202450727
Mar 202445918
Apr 202438725
May 202438911
Jun 202426321
Jul 202449214
Aug 202447523
Sep 2024481215
Oct 2024331318
Nov 202430628
Dec 20242048
Back to top
Posted November 30, 2021.
Download PDF
Data/Code
Email
The immunogenicity and safety of different COVID-19 booster vaccination following CoronaVac or ChAdOx1 nCoV-19 primary series
Nasikarn Angkasekwinai, Suvimol Niyomnaitham, Jaturong Sewatanon, Supaporn Phumiamorn, Kasama Sukapirom, Sansnee Senawong, Surakameth Mahasirimongkol, Zheng Quan Toh, Pinklow Umrod, Thitiporn Somporn, Supaporn Chumpol, Kanokphon Ritthitham, Kulkanya Chokephaibulkit
medRxiv 2021.11.29.21266947; doi: https://doi.org/10.1101/2021.11.29.21266947
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area